Key Takeaways
- Mixed quarter, TAN-led future: Urea volumes dipped on a plant stoppage while P&K and agrochemicals surged, but the call's center of gravity was the upcoming TAN plant, now set for a January 2026 start with management confident of a quick ramp.
- Agrochemical margins hit ~30%: Crop protection delivered a standout quarter, with margins far above the historical 18-20% guided range, driven by new product introductions and a placement strategy management declined to detail.
- Working capital swelled on P&K success: Receivables jumped ~₹2,100 crore YoY as higher P&K sales, coupled with a high DAP subsidy mechanism, tied up cash that management expects to largely unwind by December.
- TAN economics hinted, not guided: Management declined to give revenue or margin guidance but offered a 6-7 year payback target and a "healthy four-digit, five-digit margin per ton" at a 240,000-ton annual capacity.
- What to watch next quarter: The TAN plant's trial run in December and first product hitting the market by mid-February, the pace of receivables liquidation, and whether agrochemical margins can hold near 30%.
TAN Project: The Next Growth Engine
- Timeline firming up: All statutory approvals are in place, ₹1,052 crore spent through September 2025, and the nitric acid trial run starts in December, with product reaching the market by mid-February 2026.
- Revenue recognition targeted for Q4: Management is "hopeful" of booking TAN sales in Q4 FY26 itself, with full capacity utilization expected by the second half of FY27.
- Product lines and a premium pivot: The plant will produce nitric acid (WNA), AN melt, and HDAN. Engineering work is already underway for LDAN, a more premium product, with foundations and provisions built into the original project.
- Captive ammonia is the moat: In-house ammonia feed is a major strategic advantage, with demand linked to infrastructure, power, and coal production. Initial buyer discussions are described as encouraging.
- Expansion optionality baked in: If the first line establishes credentials, the board may gain confidence for expansion at this or another location. A co-located LDAN line would have a much shorter timeline than the initial project.
Abhay Baijal: "Should we be able to do that successfully, I'm sure the board will get the confidence to do expansion activities in this, whether in this location or some other."
Agrochemicals & Biologicals: The Margin Surprise
- Crop protection margins hit ~30%: This is well above the historical 18-20% guided range, driven by a placement strategy, 22 new product introductions in H1, and increased farmer engagement under the Uttam brand.
- Growth defied an industry downturn: Unseasonal rainfall caused negative growth for most agrochemical companies, yet Chambal posted strong double-digit YoY growth by shifting stocks to pockets where rains were earlier or later, targeting paddy and cotton crops.
- Biologicals scaled 80% YoY: H1 revenue reached ₹73 crore versus ₹40 crore last year. The portfolio is 100% biological, with bio-stimulants in the process of being added.
- Trade partners now enthusiastic: Management noted that channel partners, once experimental, are now enthusiastic about the complete farming solution approach that bundles nutrients, water solubles, and other elements.
Abhay Baijal: "Marketing is a complex exercise. You don't know what clicks when. But I think more or less we have got the chemistry in this right. That's all I can say."
Fertiliser Operations: Urea Stumble, P&K Surge
- Urea volumes hit by a plant stoppage: Gadepan-3 lost a week of production when a scrapper arm in a 24-25 meter structure broke, requiring a full stoppage for repair. Gadepan-2 had already lost ~55,000 tons in prior quarters due to syngas compressor limitations.
- Unseasonal rains disrupted offtake: September rains disrupted urea distribution and sales, but the shortfall was made up in October. Management expects to largely recover lost volumes between Gadepan-1 and Gadepan-3, though Gadepan-2 enters a planned turnaround in February.
- P&K revenues jumped on higher volumes and prices: Tonnages nearly doubled from 5.5 lakh tons to almost 11 lakh tons, enabled by government policy and expanded geographies into Maharashtra and West Bengal. Some farmers are substituting NPKs for DAP in northern regions, a shift management views as structural, not temporary.
- DAP margin compression is coming: Procurement prices swung from $650 to $850 per ton in sympathy with global DAP prices. The extent to which this can be passed on to farmers is limited, so margin compression for importers like Chambal is expected going forward.
- Receivables swelled on subsidy mechanics: Higher P&K sales drove a ~₹2,100 crore increase in receivables. The high DAP subsidy of ~₹50,000-52,000 per ton under the advantage-disadvantage mechanism causes accumulation; most stocks are expected to liquidate by end-December, with outstanding subsidy trued up by Q4.
Abhay Baijal: "Chambal has been very careful in purchasing, how and where and what time it has purchased. In fact, in the last two deals that we did, we were at the lowest number for the period of a fortnightly period."
Portfolio Strategy: Full-Stack Agri-Input
- Three-pillar nutrition strategy: Chambal wants to be present across all nutrition (urea, NPKs, potash), specialty nutrients (sulphur, zinc, manganese, micronutrients, water-soluble fertilisers), and biological segments.
- Ammonium sulphate under evaluation: The government has brought ammonium sulphate under subsidy and is pitching it as an alternative; Chambal is looking at it as a portfolio addition for the coming Kharif season.
- Seed business still nascent: At just 1% of traded products volumes and ~₹8 crore in H1 revenue, seeds are at an early stage. A mustard seed hybrid was introduced in Q2 and a wheat research variety in Q3.
- Digital farmer connect app launched: The app has 80,000-90,000 subscribers and a stiff target of 3-5 lakh by next year. It is purely for education and product information; nothing is sold through it, with all sales remaining through the channel.
- GST notice dismissed as frivolous: A notice from a Bihar officer sought to levy GST on the subsidy component. Management stated the law is clear that GST applies on MRP, not subsidy, and expects the rectification application to succeed, calling the notice one that "will not stand in appeal/court."
Urea Policy & Expansion Optionality
- Structural deficit supports new capacity: By 2029/2030, urea consumption is projected at 4.25-4.3 crore metric tons, creating a shortfall of ~1.2 crore metric tons if no new plants are built. The government is cognizant of supply disruption risks in Rabi.
- Policy discussions underway, no timeline: Management confirmed that discussions about allowing further urea production through policy have occurred, but "when and how they will come to this situation, I do not know." Nothing is on paper yet.
- Chambal ready if policy opens: Capacity exists at the current location, and a new plant would be standard-sized like Gadepan-3. The company will evaluate when an opportunity presents.
Abhay Baijal: "These factors do weigh heavily in the minds of our policy planners. And there is, therefore, a very serious case for allowing further production in India through the policy, which I'm sure they must be cogitating and thinking about."
Capital Allocation & Balance Sheet
- TAN payback targeted at 6-7 years: Management declined to share IRR but stated Chambal "always invests in businesses with a payback" and wants this one between six and seven years.
- Capex beyond TAN under development: Apart from remaining TAN spend, the company is continuously investing in energy efficiency and replacement. A new plan is being developed and could come in the FY26-27 timeframe if the Board approves.
- Two guardrails for deployment: Any new investment must be in allied lines of business and must meet a certain return threshold. Management noted these stringent conditions take time to develop projects.
- IMACID JV expanding: The Morocco phosphoric acid JV is performing well with better margins, and capacity expansion from 5 lakh to 7 lakh metric tons is expected by December 2026.
Abhay Baijal: "We have got two guardrails in this. One, that we have to be in the allied lines of business. And secondly, we have to have a certain return. So we have to meet these two stringent conditions to get it passed from the Board and that takes some time in developing."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| TAN plant trial run | Nitric acid part starts trial production | December 2025 |
| TAN first product to market | Product hits the market | Mid-February 2026 |
| TAN revenue recognition | First sales booked | Q4 FY26 |
| TAN full capacity utilization | 240,000 tons/year fully utilized | Second half of FY27 |
| TAN investment payback | Full payback achieved | 6-7 years |
| Receivables liquidation | Most stocks converted to cash | End of December 2025 |
| Subsidy outstanding trued up | Remaining subsidy received | Q4 FY26 |
| Gadepan-2 turnaround | Planned maintenance shutdown | February 2026 |
| IMACID capacity expansion | Phosphoric acid capacity to 7 lakh MT | December 2026 |
| Digital Farmer Connect subscribers | Reach 3-5 lakh subscribers | Next year (FY27) |
| DAP margins | Compression expected for importers | Going forward |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Standalone revenue | ₹6,413 cr, vs ₹4,346 cr in Q2 FY25 |
| Standalone EBITDA | ₹882 cr, vs ₹834 cr in Q2 FY25 |
| Standalone PAT | ₹602 cr, vs ₹500 cr in Q2 FY25, growth of 20% |
| H1 FY26 standalone revenue | ₹12,110 cr, vs ₹9,279 cr in H1 FY25 |
| H1 FY26 standalone EBITDA | ₹1,812 cr, vs ₹1,776 cr in H1 FY25 |
| H1 FY26 standalone PAT | ₹1,240 cr, vs ₹1,053 cr in H1 FY25, growth of 18% |
| Urea production | 8.81 lakh MT, vs 9.09 lakh MT in Q2 FY25; impacted by unscheduled stoppage at Gadepan-III |
| Urea sales | 9.34 lakh MT, vs 9.65 lakh MT in Q2 FY25 |
| P&K fertiliser revenue increase | ~₹2,100 cr higher sales vs Q2 FY25, driven by higher volumes and prices |
| Crop Protection & Speciality Nutrient revenue | ₹374 cr, vs ₹289 cr in Q2 FY25, growth of ~29% YoY |
| Crop Protection & Speciality Nutrient contribution | ₹114 cr, vs ₹83 cr in Q2 FY25, growth of 37% |
| Biological segment H1 FY26 revenue | ₹73 cr, vs ₹40 cr in H1 FY25, growth of 80% |
| TAN plant capex spent till Sep '25 | ₹1,052 cr; trial runs expected December, commercial sales by mid-February |
| Cash on books | ~₹700 cr |
| Gas cost (NCV basis) | ~$15 per MMBtu |
| Dealer network | ~5,000 dealers; ~40,000 retail outlets in private sector |